$CME Cashflow Statement | Understand Stock

$CME

$293.36 -$0.12 (0.04%) After hours

$CME Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation
Amortization of purchased intangibles
Depreciation and amortization
Net losses on assets held for sale and impaired
Gain on sale of building
Gain on joint venture
(Gain)/Loss on derivative contracts
Net realized and unrealized gains on investments
Undistributed earnings, net of losses, of unconsolidated subsidiaries
Deferred income taxes
Change in assets and liabilities:
Accounts receivable
Other current assets
Other assets
Accounts payable
Income tax payable
Other current liabilities
Other liabilities
Other

Net Cash Provided by Operating Activities
Cash Flows from Investing Activities
Proceeds from maturities and sales of available-for-sale marketable securities
Purchases of available-for-sale marketable securities
Purchases of property, net
Investments in business ventures
Proceeds from sale of business ventures
Payment for acquisition of subsidiary's interests from the non-controlling interest
Proceeds from the sale of building property
Net cash proceeds from OSTTRA joint venture transaction
Investment in S&P Dow Jones Indices LLC
Net Cash Used in Investing Activities
Cash Flows from Financing Activities
Repayment issuance of commercial paper, net
Proceeds from debt, net of issuance costs
Repayment of other borrowings, including call premiums
Proceeds from preferred stock offering
Cash dividends
Payments for (Proceeds from) Derivative Instrument, Financing Activities
Change in performance bond and guaranty fund contributions
Employee taxes paid on restricted stock vesting
Other
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance
Supplemental Disclosure of Cash Flow Information
Cash and cash equivalents
Short-term restricted cash (within other current assets)
Long-term restricted cash (within other assets)
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)
Income taxes paid
Interest paid
Dividends declared

Comments